Back to Authors

Patel, Dharmendra R.

Mayo Clinic

Mayo Clinic in Arizona

Citations 2

A Disposable Tear Glucose Biosensor—Part 4
Belle, Jeffrey T. La , Engelschall, Erica, Lan, Kenneth, Shah, Pankti, Saez, Neil , Maxwell, Stephanie, Adamson, Teagan, Abou-Eid, Michelle, McAferty, Kenyon, Patel, Dharmendra, Patel, Dharmendra R., Cook, Curtiss B.

Journal of Diabetes Science and Technology | February 11, 2014 | Volume: 8 | Issue: 1 | Pages: 109-116

10.1177/1932296813511741 Get It

Objective: A prototype tear glucose (TG) sensor was tested in New Zealand white rabbits to assess eye irritation, blood glucose (BG) and TG lag time, and correlation with BG. Methods: A total of 4 animals were used. Eye irritation was monitored by Lissamine green dye and analyzed using image analysis software. Lag time was correlated with an oral glucose load while recording TG and BG readings. Correlation between TG and BG were plotted against one another to form a correlation diagram, using a Yellow Springs Instrument (YSI) and self-monitoring of blood glucose as the reference measurements. Finally, TG levels were calculated using analytically derived expressions. Results: From repeated testing carried over the course of 12 months, little to no eye irritation was detected. TG fluctuations over time visually appeared to trace the same pattern as BG with an average lag times of 13 minutes. TG levels calculated from the device current measurements ranged from 4 to 20 mg/dL and correlated linearly with BG levels of 75-160 mg/dL (TG = 0.1723 BG = 7.9448 mg/dL; R 2 = .7544). Conclusion: The first steps were taken toward preliminary development of a sensor for self-monitoring of tear glucose (SMTG). No conjunctival irritation in any of the animals was noted. Lag time between TG and BG was found to be noticeable, but a quantitative modeling to correlate lag time in this study is unnecessary. Measured currents from the sensors and the calculated TG showed promising correlation to BG levels. Previous analytical bench marking showed BG and TG levels consistent with other literature.
A Disposable Tear Glucose Biosensor—Part 2: System Integration and Model Validation
Belle, Jeffrey T. La , Bishop, D. Keith, Vossler, S. R., Patel, Dharmendra R., Patel, Dharmendra R., Cook, Curtiss B.

Journal of Diabetes Science and Technology | January 10, 2014 | Volume: 4 | Issue: 2 | Pages: 307-311

10.1177/193229681000400210 Get It

Background: We presented a concept for a tear glucose sensor system in an article by Bishop and colleagues in this issue of Journal of Diabetes Science and Technology . A unique solution to collect tear fluid and measure glucose was developed. Individual components were selected, tested, and optimized, and system error modeling was performed. Further data on prototype testing are now provided. Methods: An integrated fluidics portion of the prototype was designed, cast, and tested. A sensor was created using screen-printed sensors integrated with a silicone rubber fluidics system and absorbent polyurethane foam. A simulated eye surface was prepared using fluid-saturated poly(2-hydroxyethyl methacrylate) sheets, and the disposable prototype was tested for both reproducibility at 0, 200, and 400 μ M glucose ( n = 7) and dynamic range of glucose detection from 0 to 1000 μ M glucose. Results: From the replicated runs, an established relative standard deviation of 15.8% was calculated at 200 μ M and a lower limit of detection was calculated at 43.4 μ M . A linear dynamic range was demonstrated from 0 to 1000 μ M with an R 2 of 99.56%. The previously developed model predicted a 14.9% variation. This compares to the observed variance of 15.8% measured at 200 μ M glucose. Conclusion: With the newly designed fluidics component, an integrated tear glucose prototype was assembled and tested. Testing of this integrated prototype demonstrated a satisfactory lower limit of detection for measuring glucose concentration in tears and was reproducible across a physiological sampling range. The next step in the device design process will be initial animal studies to evaluate the current prototype for factors such as eye irritation, ease of use, and correlation with blood glucose.